Product image of Levetiracetam Biomo (Levetiracetam) supplied by GNH India

Levetiracetam Biomo

Active Ingredient:
Levetiracetam
Origin:
EU

Levetiracetam Biomo (Levetiracetam)

Levetiracetam, the active ingredient in Levetiracetam Biomo, is an anticonvulsant presented as an oral dosage form for oral use. It belongs to the antiepileptic drug class and is prescribed to manage various seizure types in patients with epilepsy, including partial‑onset, generalized tonic‑clonic, and myoclonic seizures.

GNH India supplies Levetiracetam Biomo as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies, and clinics worldwide, providing reliable sourcing for regulated markets. The company adheres to stringent quality standards and offers comprehensive logistics support.

Manufacturer / TM Owner

Biomo Pharma Gmbh

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

  • Levetiracetam is an antiepileptic medication that reduces neuronal excitability in seizure disorders.
  • Partial‑onset seizures: reduces frequency of focal seizures in patients with epilepsy.
  • Generalized tonic‑clonic seizures: helps control convulsive episodes in generalized epilepsy.
  • Myoclonic seizures: decreases myoclonic jerks in appropriate patient populations.

How It Works

  • Levetiracetam binds to the synaptic vesicle protein SV2A, modulating neurotransmitter release and stabilizing neuronal membranes. This interaction reduces excessive synaptic firing and neuronal excitability, thereby diminishing the propagation of seizure activity across the central nervous system. The precise downstream pathways remain under investigation, but the overall effect is a net decrease in hyper‑synchronous neuronal discharge that underlies epileptic events. This mechanism is independent of traditional sodium or calcium channel blockade.

Side Effects

Levetiracetam may be associated with a range of adverse reactions, varying from mild to severe.

Common Side Effects

  • Dizziness: sensation of lightheadedness or unsteadiness.
  • Fatigue: feeling unusually tired or weak.
  • Headache: mild to moderate cranial pain.
  • Irritability: increased mood swings or agitation.

Serious or Rare Side Effects

  • Severe allergic reaction: rash, swelling, or difficulty breathing.
  • Mood or behavior changes: depression, suicidal thoughts, or aggression.
  • Blood disorders: signs of low blood cell counts such as bruising or infections.

Precautions & Warnings

When prescribing Levetiracetam, clinicians should consider several precautionary measures to ensure patient safety.

  • Renal function: adjust dose in patients with impaired renal clearance.
  • Psychiatric history: monitor for mood alterations or suicidal ideation.
  • Concomitant CNS depressants: use caution as additive sedation may occur.
  • Pregnancy status: evaluate risks versus benefits before use.
  • Driving and operating machinery: advise patients about possible dizziness or drowsiness.
  • Store at ambient temperature: keep below 25°C in the original packaging, protected from moisture.

Avoid Interactions

Levetiracetam can interact with other medicines, influencing its efficacy or safety profile.

Major Interactions (Avoid)

  • Carbamazepine: may reduce levetiracetam plasma levels, decreasing effectiveness.
  • Phenobarbital: can lower levetiracetam concentrations, potentially compromising seizure control.

Moderate Interactions (Monitor Closely)

  • Alcohol: combined use may enhance central nervous system depression.
  • Sedative antihistamines: may increase drowsiness when taken together.
  • Other antiepileptic drugs: monitor for additive side effects or altered seizure control.

Frequently Asked Questions

Levetiracetam Biomo is used to treat epilepsy by reducing the frequency of partial‑onset, generalized tonic‑clonic, and myoclonic seizures. It is prescribed for patients who require an oral antiepileptic medication to control seizure activity and improve overall neurological stability.

Levetiracetam works by binding to the synaptic vesicle protein SV2A, which modulates neurotransmitter release. This action stabilizes neuronal membranes and lowers excessive synaptic firing, thereby decreasing the likelihood of seizure propagation throughout the central nervous system.

The appropriate dose of Levetiracetam Biomo is individualized by the prescribing clinician based on factors such as the patient’s age, weight, renal function, seizure type, and response to therapy. No fixed regimen is provided here; the prescriber sets the dosage.

Safety data for levetiracetam in pregnancy and lactation are limited. Clinicians must weigh potential benefits against possible risks, and the decision should be made on a case‑by‑case basis after consulting current guidelines and the patient’s obstetric history.

To order, submit an enquiry on the product page at gnhindia.com indicating the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Levetiracetam offers a distinct mechanism (SV2A binding) and generally has fewer drug‑enzyme interactions than agents such as carbamazepine or phenytoin. It is often chosen for its favorable pharmacokinetic profile, but efficacy and tolerability should be compared individually for each patient.

Levetiracetam Biomo should be stored at ambient temperature, preferably below 25 °C. Keep the product in its original packaging, protect it from moisture, and avoid exposure to direct sunlight to maintain stability.

The medication is taken orally, usually with or without food, as directed by the prescriber. Swallow tablets whole with a glass of water; do not crush or chew unless specifically instructed.

Serious risks include severe allergic reactions (rash, swelling, breathing difficulty), significant mood or behavior changes such as depression or suicidal thoughts, and rare blood disorders that may present as unexplained bruising or infections. Prompt medical attention is required if these occur.

Patients with known hypersensitivity to levetiracetam or any of its excipients should avoid the product. Caution is also advised for individuals with severe renal impairment, uncontrolled psychiatric conditions, or those taking interacting medications listed under major interactions.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Levetiracetam

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT